Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion description "[The MCT1 inhibitor CHC exhibited anti-tumoral and anti-angiogenic activity in gliomas and, of importance, enhanced the effect of temozolomide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion evidence source_evidence_literature NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion SIO_000772 23258846 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion wasDerivedFrom befree-20140225 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion wasGeneratedBy ECO_0000203 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- befree-20140225 importedOn "2014-02-25" NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.